Rare diseases
Investigational molecules
Locations
Back to Portugal98 clinical trials in Almada, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke
PortugalStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
PortugalStudy on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17
PortugalStudy on the Effectiveness and Safety of Sublingual MM09 for Patients Aged 12-65 with Allergies to House Dust Mites and Rhinitis/Rhinoconjunctivitis with or without Asthma
PortugalPortugalStudy of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years
PortugalStudy on VE303 for Preventing Recurrent C. difficile Infection in Patients
PortugalLong-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine
PortugalStudy on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury
PortugalStudy on the Effectiveness and Safety of Treprostinil and Drug Combination for Patients with Pulmonary Arterial Hypertension (Group I)
PortugalStudy on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine
PortugalStudy on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission
PortugalThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary arterial hypertension and chronic obstructive pulmonary disease, evaluating novel treatments including ralinepag and itepekimab for long-term management of these conditions.
Research investigating treatments for systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, with studies on medications like upadacitinib and remibrutinib.
Studies examining treatments for multiple sclerosis, migraine prevention, and neurological conditions, testing medications such as ocrelizumab and atogepant.
Investigations into hypertrophic cardiomyopathy and stroke prevention, studying treatments like mavacamten and asundexian for improved cardiac outcomes.
Advanced studies in lung cancer, colorectal cancer, and head and neck cancers, evaluating novel immunotherapy combinations and targeted treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
